Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewClinical ResearchInflammation Open Access | 10.1172/jci.insight.206938

Mapping the plasma proteomic architecture of systemic lupus erythematosus

Geoffrey H. D. Leung,1 Charlotte Bottomley,1 Norzawani Buang,1 Robert T. Maughan,1 Benjamin J. Whittle,1 Boroumand Zeidaabadi,1 Yun-Ju Huang,1 Tabitha Turner-Stokes,1 Marie Condon,2 Liz Lightstone,1 Tom Cairns,2 Marina Botto,1 Matthew C. Pickering,1 and James E. Peters1

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Leung, G. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Bottomley, C. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Buang, N. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Maughan, R. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Whittle, B. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Zeidaabadi, B. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Huang, Y. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Turner-Stokes, T. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Condon, M. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Lightstone, L. in: PubMed | Google Scholar |

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Cairns, T. in: PubMed | Google Scholar

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Botto, M. in: PubMed | Google Scholar |

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Pickering, M. in: PubMed | Google Scholar |

1Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

2Imperial Lupus Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

Find articles by Peters, J. in: PubMed | Google Scholar

Published June 2, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.206938.
Copyright © 2026, Leung et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 2, 2026 - Version history
View PDF
Abstract

Systemic lupus erythematosus (SLE) is a heterogeneous systemic autoimmune disease, yet the molecular basis underlying this variability remains incompletely understood. We profiled the plasma proteome in 260 SLE patients and 86 healthy volunteers (HVs) using the SomaScan v4.1 platform, quantifying 7,288 analytes corresponding to 6,595 unique proteins. We identified 215 proteins that were robustly differentially abundant between SLE patients and HVs in both discovery (n=207 SLE, n=45 HVs) and validation sets (n=53 SLE, n=41 HVs). Within-cases analyses identified 421 proteins associated with disease activity. Network-based clustering delineated correlated protein modules, including an interferon-associated module and a renal-associated module. Autoantibody-stratified analyses further uncovered distinct proteomic endotypes: positivity for antibodies targeting RNA-binding proteins (anti-Sm, anti-Ro-60, anti-RNP68, anti-RNP-A) was associated with increased interferon-stimulated protein levels (e.g., MX1, ISG15, CXCL10), independent of disease activity. Anti-Sm, anti-RNP-A and anti-Ro52 antibodies were associated with reduced plasma levels of their respective autoantigens. Anti-dsDNA antibodies were associated with elevated levels of CD40 ligand (CD40LG) and the neutrophil protease proteinase-3. Moreover, we identified an association between CD40LG and disease activity specific to the anti-dsDNA positive subgroup. Together, these data define plasma protein signatures of SLE and disease activity, highlight autoantibody-specific molecular phenotypes, and provide a basis for precision medicine.

Graphical Abstract
graphical abstract
Supplemental material

View Supplementary Data 1-15

View

Version history
  • Version 1 (June 2, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts